Providing Ophthalmic Instruments and Accessories to the

Jersey City, NJ—The FDA has granted orphan drug designation to two investigational therapeutics of Lux Biosciences, a privately held biotechnical company specializing in treatments for ophthalmic diseases. (Source: Ophthalmology Times - Ophthalmic News)